{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T08:40:30Z","timestamp":1774600830850,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T00:00:00Z","timestamp":1604102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T00:00:00Z","timestamp":1604102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2017R1D1A1B06028086"],"award-info":[{"award-number":["NRF-2017R1D1A1B06028086"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2019R1G1A1099554"],"award-info":[{"award-number":["NRF-2019R1G1A1099554"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Catholic Medical Center Research Foundation","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s10072-020-04859-8","type":"journal-article","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T03:02:39Z","timestamp":1604113359000},"page":"711-718","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Neuropsychiatric symptoms and striatal monoamine availability in early Parkinson\u2019s disease without dementia"],"prefix":"10.1007","volume":"42","author":[{"given":"Yoon-Sang","family":"Oh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Won","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eo-Jin","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul Hyoung","family":"Lyoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8087-7977","authenticated-orcid":false,"given":"Joong-Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,31]]},"reference":[{"issue":"8","key":"4859_CR1","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1136\/jnnp.2008.166959","volume":"80","author":"D Aarsland","year":"2009","unstructured":"Aarsland D, Bronnick K, Alves G, Tysnes OB, Pedersen KF, Ehrt U, Larsen JP (2009) The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 80(8):928\u2013930. https:\/\/doi.org\/10.1136\/jnnp.2008.166959","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"4859_CR2","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/jnnp.67.4.492","volume":"67","author":"D Aarsland","year":"1999","unstructured":"Aarsland D, Larsen JP, Lim NG, Janvin C, Karlsen K, Tandberg E, Cummings JL (1999) Range of neuropsychiatric disturbances in patients with Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 67(4):492\u2013496. https:\/\/doi.org\/10.1136\/jnnp.67.4.492","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"4859_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/jnnp.2005.083113","volume":"78","author":"D Aarsland","year":"2007","unstructured":"Aarsland D, Bronnick K, Ehrt U, De Deyn PP, Tekin S, Emre M, Cummings JL (2007) Neuropsychiatric symptoms in patients with Parkinson\u2019s disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry 78(1):36\u201342. https:\/\/doi.org\/10.1136\/jnnp.2005.083113","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"13","key":"4859_CR4","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1002\/mds.22246","volume":"23","author":"J Kulisevsky","year":"2008","unstructured":"Kulisevsky J, Pagonabarraga J, Pascual-Sedano B, Garcia-Sanchez C, Gironell A, Trapecio Group Study (2008) Prevalence and correlates of neuropsychiatric symptoms in Parkinson\u2019s disease without dementia. Mov Disord 23(13):1889\u20131896. https:\/\/doi.org\/10.1002\/mds.22246","journal-title":"Mov Disord"},{"issue":"6","key":"4859_CR5","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/ene.13002.","volume":"23","author":"MC Wen","year":"2016","unstructured":"Wen MC, Chan LL, Tan LC, Tan EK (2016) Depression, anxiety, and apathy in Parkinson\u2019s disease: insights from neuroimaging studies. Eur J Neurol 23(6):1001\u20131019. https:\/\/doi.org\/10.1111\/ene.13002.","journal-title":"Eur J Neurol"},{"issue":"9","key":"4859_CR6","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.parkreldis.2012.05.022","volume":"18","author":"R Erro","year":"2012","unstructured":"Erro R, Pappata S, Amboni M, Vicidomini C, Longo K, Santangelo G, Picillo M, Vitale C, Moccia M, Giordano F, Brunetti A, Pellecchia MT, Salvatore M, Barone P (2012) Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson\u2019s disease patients. Parkinsonism Relat Disord 18(9):1034\u20131038. https:\/\/doi.org\/10.1016\/j.parkreldis.2012.05.022","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"4859_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/jnnp-2012-304,811","volume":"85","author":"C Vriend","year":"2014","unstructured":"Vriend C, Raijmakers P, Veltman DJ, van Dijk KD, van der Werf YD, Foncke EM, Smit JH, Berendse HW, van den Heuvel OA (2014) Depressive symptoms in Parkinson\u2019s disease are related to reduced [123I]FP-CIT binding in the caudate nucleus. J Neurol Neurosurg Psychiatry 85(2):159\u2013164. https:\/\/doi.org\/10.1136\/jnnp-2012-304,811","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"4859_CR8","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00259-012-2232-7","volume":"39","author":"D Di Giuda","year":"2012","unstructured":"Di Giuda D, Camardese G, Bentivoglio AR, Cocciolillo F, Guidubaldi A, Pucci L, Bruno I, Janiri L, Giordano A, Fasano A (2012) Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study. Eur J Nucl Med Mol Imaging 39(12):1937\u20131948. https:\/\/doi.org\/10.1007\/s00259-012-2232-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"4859_CR9","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.parkreldis.2015.02.015","volume":"21","author":"G Santangelo","year":"2015","unstructured":"Santangelo G, Vitale C, Picillo M, Cuoco S, Moccia M, Pezzella D, Erro R, Longo K, Vicidomini C, Pellecchia MT, Amboni M, Brunetti A, Salvatore M, Barone P, Pappata S (2015) Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson\u2019s disease patients. Parkinsonism Relat Disord 21(5):489\u2013493. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.02.015","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"4859_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10072-018-3632-7","volume":"40","author":"SB Park","year":"2019","unstructured":"Park SB, Kwon KY, Lee JY, Im K, Sunwoo JS, Lee KB, Roh H, Ahn MY, Park S, Kim SJ, Oh JS, Kim JS (2019) Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson\u2019s disease: a detailed PET analysis of 12 striatal subregions. Neurol Sci 40(2):311\u2013317. https:\/\/doi.org\/10.1007\/s10072-018-3632-7","journal-title":"Neurol Sci"},{"key":"4859_CR11","doi-asserted-by":"publisher","unstructured":"Koch W, Unterrainer M, Xiong G, Bartenstein P, Diemling M, Varrone A, Dickson JC, Tossici-Bolt L, Sera T, Asenbaum S, Booij J, Kapucu OL, Kluge A, Ziebell M, Darcourt J, Nobili F, Pagani M, Hesse S, Vander Borght T, Van Laere K, Tatsch K, la Foug\u00e8re C (2014) Extrastriatal binding of [(1)(2)(3)I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls. Eur J Nucl Med Mol Imaging 41(10):1938\u20131946. doi: https:\/\/doi.org\/10.1007\/s00259-014-2785-8.","DOI":"10.1007\/s00259-014-2785-8"},{"issue":"6","key":"4859_CR12","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"WR Gibb","year":"1988","unstructured":"Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 51(6):745\u2013752. https:\/\/doi.org\/10.1136\/jnnp.51.6.745","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"4859_CR13","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"issue":"7","key":"4859_CR14","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3346\/jkms.2010.25.7.1071","volume":"25","author":"HJ Ahn","year":"2010","unstructured":"Ahn HJ, Chin J, Park A, Lee BH, Suh MK, Seo SW, Na DL (2010) Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients. J Korean Med Sci 25(7):1071\u20131076. https:\/\/doi.org\/10.3346\/jkms.2010.25.7.1071","journal-title":"J Korean Med Sci"},{"issue":"3","key":"4859_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan I, Goldman JG, Tr\u00f6ster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012) Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society Task Force guidelines. Mov Disord 27(3):349\u2013356. https:\/\/doi.org\/10.1002\/mds.24893","journal-title":"Mov Disord"},{"issue":"12","key":"4859_CR16","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord 22(12):1689\u20131707. https:\/\/doi.org\/10.1002\/mds.21507","journal-title":"Mov Disord"},{"issue":"7","key":"4859_CR17","doi-asserted-by":"publisher","first-page":"e0132585","DOI":"10.1371\/journal.pone.0132585","volume":"10","author":"JS Kim","year":"2015","unstructured":"Kim JS, Cho H, Choi JY, Lee SH, Ryu YH, Lyoo CH, Lee MS (2015) Feasibility of computed tomography-guided methods for spatial normalization of dopamine transporter positron emission tomography image. PLoS One 10(7):e0132585. https:\/\/doi.org\/10.1371\/journal.pone.0132585","journal-title":"PLoS One"},{"issue":"7","key":"4859_CR18","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1002\/mds.26170","volume":"30","author":"D Weintraub","year":"2015","unstructured":"Weintraub D, Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Siderowf A, Aarsland D, Barone P, Burn D, Chahine LM, Eberling J, Espay AJ, Foster ED, Leverenz JB, Litvan I, Richard I, Troyer MD, Hawkins KA, Parkinson\u2019s Progression Markers Initiative (2015) Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson\u2019s disease. Mov Disord 30(7):919\u2013927. https:\/\/doi.org\/10.1002\/mds.26170","journal-title":"Mov Disord"},{"issue":"7","key":"4859_CR19","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/arclin\/acx091","volume":"32","author":"SJ Getz","year":"2017","unstructured":"Getz SJ, Levin B (2017) Cognitive and neuropsychiatric features of early Parkinson\u2019s disease. Arch Clin Neuropsychol 32(7):769\u2013785. https:\/\/doi.org\/10.1093\/arclin\/acx091","journal-title":"Arch Clin Neuropsychol"},{"issue":"6","key":"4859_CR20","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/brain\/awh445","volume":"128","author":"P Remy","year":"2005","unstructured":"Remy P, Doder M, Lees A, Turjanski N, Brooks D (2005) Depression in Parkinson\u2019s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128(6):1314\u20131322. https:\/\/doi.org\/10.1093\/brain\/awh445","journal-title":"Brain"},{"issue":"1","key":"4859_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00213-010-1867-y","volume":"211","author":"AC Felicio","year":"2010","unstructured":"Felicio AC, Moriyama TS, Godeiro-Junior C, Shih MC, Hoexter MQ, Borges V, Silva SM, Amaro-Junior E, Andrade LA, Ferraz HB, Bressan RA (2010) Higher dopamine transporter density in Parkinson\u2019s disease patients with depression. Psychopharmacology (Berl) 211(1):27\u201331. https:\/\/doi.org\/10.1007\/s00213-010-1867-y","journal-title":"Psychopharmacology (Berl)"},{"key":"4859_CR22","doi-asserted-by":"publisher","first-page":"104563","DOI":"10.1016\/j.nbd.2019.104563","volume":"132","author":"SW Yoo","year":"2019","unstructured":"Yoo SW, Oh YS, Hwang EJ, Ryu DW, Lee KS, Lyoo CH, Kim JS (2019) \u201cDepressed\u201d caudate and ventral striatum dopamine transporter availability in de novo Depressed Parkinson\u2019s disease. Neurobiol Dis. 132:104563. https:\/\/doi.org\/10.1016\/j.nbd.2019.104563","journal-title":"Neurobiol Dis."},{"issue":"3","key":"4859_CR23","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1468-1331.2012.03878.x","volume":"20","author":"R Ceravolo","year":"2013","unstructured":"Ceravolo R, Frosini D, Poletti M, Kiferle L, Pagni C, Mazzucchi S, Volterrani D, Bonuccelli U (2013) Mild affective symptoms in de novo Parkinson\u2019s disease patients: relationship with dopaminergic dysfunction. Eur J Neurol 20(3):480\u2013485. https:\/\/doi.org\/10.1111\/j.1468-1331.2012.03878.x","journal-title":"Eur J Neurol"},{"issue":"1","key":"4859_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/jnnp-2017-316,193.","volume":"89","author":"M Joling","year":"2018","unstructured":"Joling M, van den Heuvel OA, Berendse HW, Booij J, Vriend C (2018) Serotonin transporter binding and anxiety symptoms in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 89(1):89\u201394. https:\/\/doi.org\/10.1136\/jnnp-2017-316,193.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4859_CR25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.parkreldis.2017.02.010","volume":"37","author":"M Picillo","year":"2017","unstructured":"Picillo M, Santangelo G, Erro R, Cozzolino A, Amboni M, Vitale C, Barone P, Pellecchia MT (2017) Association between dopaminergic dysfunction and anxiety in de novo Parkinson\u2019s disease. Parkinsonism Relat Disord 37:106\u2013110. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.02.010","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"4859_CR26","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/npp.2009.104","volume":"35","author":"JL Price","year":"2010","unstructured":"Price JL, Drevets WC (2010) Neurocircuitry of mood disorders. Neuropsychopharmacology 35(1):192\u2013216. https:\/\/doi.org\/10.1038\/npp.2009.104","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"4859_CR27","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S2215-0366(15)00232-1","volume":"2","author":"M Spies","year":"2015","unstructured":"Spies M, Knudsen GM, Lanzenberger R, Kasper S (2015) The serotonin transporter in psychiatric disorders: insights from PET imaging. Lancet Psychiatry 2(8):743\u2013755. https:\/\/doi.org\/10.1016\/S2215-0366(15)00232-1","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"4859_CR28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.nbd.2010.05.028","volume":"40","author":"M Politis","year":"2010","unstructured":"Politis M, Wu K, Loane C, Kiferle L, Molloy S, Brooks DJ, Piccini P (2010) Staging of serotonergic dysfunction in Parkinson\u2019s disease: an in vivo 11C-DASB PET study. Neurobiol Dis 40(1):216\u2013221. https:\/\/doi.org\/10.1016\/j.nbd.2010.05.028","journal-title":"Neurobiol Dis"},{"issue":"1","key":"4859_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00415-010-5666-5","volume":"258","author":"K Strecker","year":"2011","unstructured":"Strecker K, Wegner F, Hesse S, Becker GA, Patt M, Meyer PM, Lobsien D, Schwarz J, Sabri O (2011) Preserved serotonin transporter binding in de novo Parkinson\u2019s disease: negative correlation with the dopamine transporter. J Neurol 258(1):19\u201326. https:\/\/doi.org\/10.1007\/s00415-010-5666-5","journal-title":"J Neurol"},{"issue":"9","key":"4859_CR30","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1093\/brain\/aww162.","volume":"139","author":"A Maillet","year":"2016","unstructured":"Maillet A, Krack P, Lhomm\u00e9e E, M\u00e9t\u00e9reau E, Klinger H, Favre E, Le Bars D, Schmitt E, Bichon A, Pelissier P, Fraix V, Castrioto A, Sgambato-Faure V, Broussolle E, Tremblay L, Thobois S (2016) The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson\u2019s disease. Brain 139(9):2486\u20132502. https:\/\/doi.org\/10.1093\/brain\/aww162.","journal-title":"Brain"},{"issue":"4","key":"4859_CR31","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00702-013-0988-y.","volume":"120","author":"R Monastero","year":"2013","unstructured":"Monastero R, Di Fiore P, Ventimiglia GD, Camarda R, Camarda C (2013) The neuropsychiatric profile of Parkinson\u2019s disease subjects with and without mild cognitive impairment. J Neural Transm (Vienna) 120(4):607\u2013611. https:\/\/doi.org\/10.1007\/s00702-013-0988-y.","journal-title":"J Neural Transm (Vienna)"},{"key":"4859_CR32","doi-asserted-by":"publisher","first-page":"308097","DOI":"10.1155\/2012\/308097","volume":"2012","author":"I Leroi","year":"2012","unstructured":"Leroi I, Pantula H, McDonald K, Harbishettar V (2012) Neuropsychiatric symptoms in Parkinson\u2019s disease with mild cognitive impairment and dementia. Parkinsons Dis 2012:308097. https:\/\/doi.org\/10.1155\/2012\/308097","journal-title":"Parkinsons Dis"}],"updated-by":[{"DOI":"10.1007\/s10072-020-04886-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T00:00:00Z","timestamp":1604966400000}}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04859-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-020-04859-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04859-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T11:38:06Z","timestamp":1611833886000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-020-04859-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,31]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["4859"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04859-8","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10072-020-04886-5","asserted-by":"object"}]},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,31]]},"assertion":[{"value":"22 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The originally figure 1 was published online in black and white.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Seoul St. Mary\u2019s Hospital ethics committee approved the study and all participants signed informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and Informed consent"}}]}}